Skip to content

NOVAMED GROUP

Active
Private limited companyfounded 20242 yrs activeAlfred Stevensstraat 1, 1020 Brussel, BelgiumKBO/BCE: BE 1010.684.768

NOVAMED GROUP has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €130k and a net result of €130k. Its solvency ranks better than 95% of 16527 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).

Checked score

Score 2025
93 / 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100▲+74
Solvency100▲+75
Growth78
Track record82
Bankruptcy probability, 12 months
0.4% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €12k at 30 days only on tighter terms
Liquidity ample (current ratio 16.31 against 0.28 in 2024; short-term debt: 3% and cash: 33.2% of total assets), and 3% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Eight signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies more bankruptcies →
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 2 years 0 10 y
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
raises risk · Multiple establishment units
Several establishment units mean more fixed costs, and such companies fail more often than a company with one establishment.
KBO · establishment units
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
97%
Return on assets
97%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 15-07-2026, 16 days ahead of the deadline.
NBB · 2 filings
Deviation from the deadline
2025
16 d early
2024
14 d early
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
21-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€130k
2024 · €-73
2024: €-73
2024 → 2025
Total assets
€134k▲ 164%
2024 · €51k
2024: €51k
2024 → 2025
Net result
€130k
2024 · €-4k
2024: €-4k
2024 → 2025
Working capital
€62k
2024 · €-36k
2024: €-36k
2024 → 2025
Multi-year overview
Available amounts per fiscal year
Line20242025Trend
Equity€-73-€130k
Operating result€-4k-€167k
Net result€-4k-€130k
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€-50k€0€50k€100k€150kOperating result 2024: €-4k€-4kNet result 2024: €-4k€-4kOperating result 2025: €167k€167kNet result 2025: €130k€130k20242025
The operating result returns to profit in 2025: €167k after a loss of €4k in 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €134k
Fixed assets €67k▲ 85.5%
Current assets €66k▲ 360%
Equity and liabilities €134k
Equity €130k
Debt €4k
Debt finances 3.0% of the balance-sheet total.
Key figures and ratios
2025 value · change against 2024
EBITDA
€175k
2024 · €69
Cash flow
€138k
2024 · €34
Solvency
97.0%
2024 · -0.1%
Current ratio
16.31
2024 · 0.28
Quick ratio
16.31
2024 · 0.28
Debt / equity
0.03
ROE
100.1%
ROA
97.0%
2024 · -7.0%
Interest coverage
417.09
2024 · 1.98
Debt
€4k
2024 · €51k
Debt ≤ 1 year
€4k
2024 · €51k
Income taxes
€37k
Staff costs
€32k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€51k€134k
Fixed assets21/28€36k€67k
Intangible fixed assets21€3k€2k
Tangible fixed assets22/27€26k€51k
Furniture and vehicles24€6k€33k
Other tangible fixed assets26€21k€18k
Financial fixed assets28€7k€14k
Current assets29/58€14k€66k
Amounts receivable within one year40/41-€4k
Other amounts receivable41-€4k
Cash at bank and in hand54/58€12k€44k
Deferred charges and accrued income490/1€2k€18k
Equity and liabilities
Total equity and liabilities10/49€51k€134k
Equity10/15€-73€130k
Contributions10/11€4k€4k=
Profit (loss) carried forward14€-4k€126k
Amounts payable17/49€51k€4k
Amounts payable within one year42/48€51k€4k
Trade debts44€833€204
Suppliers440/4€833€204
Taxes, remuneration and social security45-€4k
Taxes450/3-€57
Remuneration and social security454/9-€4k
Other amounts payable47/48€50k€0
Income statement Code20242025
Remuneration, social security and pensions62-€32k
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€4k€8k
Other operating charges640/8€387€1k
Gross operating margin9900€457€208k
Operating profit (loss)9901€-4k€167k
Financial charges65/66B€35€420
Recurring financial charges65€35€420
Profit (loss) for the period before taxes9903€-4k€167k
Income taxes67/77-€37k
Profit (loss) for the period9904€-4k€130k
Profit (loss) for the period to be appropriated9905€-4k€130k
Appropriation of the result
Profit (loss) to be appropriated9906€-4k€126k
Profit (loss) brought forward from the previous period14P-€-4k

The notes to these accounts (14 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
15-07
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial Back to profitnet €130k
Net result €130k after one loss-making year.
31-12
Financial Liquidity times 57current ratio 16.31
Current ratio from 0.28 to 16.31; short-term debt falls from €51k to €4k.
31-12
Financial Equity above €100kEq €130k
Equity rises from €-73 to €130k.
17-07
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Brussel · 2 establishment units since 2024
establishment All 2 establishment units on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Alfred Stevensstraat 11020 Brussel
Ground area
422 m²
Building footprint
288 m²
Volume, LiDAR
3,333 m³
3 parcels, Brussels · tallest building 19.4 m, ±5 floors. Linked by address, not a title deed.
2 establishment units
NOVAMED
Houba de Strooperlaan 101, 1020 BrusselGeneral medical practice
since 20242.361.014.642
NOVAMED DENTAL
Houba de Strooperlaan 94, 1020 BrusselGeneral medical practice
since 20262.384.717.086
3 parcels
Brussels 3 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
21816C0026/00V024 Brussels 215 m² 1 · 133 m² 19.4 m · 5 fl.
21816C0005/00A010 Brussels 127 m² 1 · 109 m² 14.7 m · 3 fl.
21816C0107/00L010 Brussels 79 m² 1 · 46 m² 8.7 m · 2 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 2
3 of 3 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 9,124 companies in sector 86210 we hold annual accounts for 6,337. 5,426 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded24-06-2024
Fiscal year end31-12
Activities, NACEBEL
86210General medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 2 filingsAddress and cadastre registers

Data from official sources, last processed on 21-09-2026. Scores and ratios are computed by Checked and are not a credit decision.

Contact details

3 entries
E-mail:soufiane.chebli@outlook.com
Enterprise
Phone:+320484990154
Enterprise
Phone:0484990154
Establishment Brussel 2.361.014.642